Advances in Nanomaterial-Mediated CRISPR/Cas Delivery: From Lipid Nanoparticles to Vesicle-Derived Systems
January 2026
in “
Frontiers in Bioengineering and Biotechnology
”
Studysummary This review discusses various nanocarriers for gene and genome editing therapies, highlighting that ionizable lipid nanoparticles show advanced delivery performance, while emerging polymer-based and exosome-inspired carriers are rapidly advancing for targeted applications.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on public-pages-files-2025.frontiersin.org →